Neisseria meningitidis serogroup A, C, Y, and W-135 capsular polysaccharide antigens (MenACWY antigens) (MenACWY)

Neisseria meningitidis serogroup A, C, Y, and W-135 capsular polysaccharide antigens are essential carbohydrate polymers that encapsulate the meningococcus, a leading cause of bacterial meningitis and sepsis [4, 11]. These polysaccharides function as primary virulence factors by providing a physical barrier that prevents host phagocytes from engulfing the bacteria and by interfering with the complement system's ability to lyse the pathogen [3, 9, 17]. Because these capsules are immunologically distinct, they define the serogroups of the bacteria and serve as the basis for diagnostic typing and vaccine development [7, 16]. In clinical practice, these antigens are utilized in quadrivalent vaccines to stimulate the host's immune system to produce protective antibodies [1, 10]. While early vaccines used plain polysaccharides, modern conjugate vaccines chemically link these sugars to carrier proteins like diphtheria or tetanus toxoid to elicit a more robust, T-cell dependent immune response [1, 13]. This conjugation allows for the induction of high-affinity antibodies and long-lasting immunological memory, even in young children [1, 6]. By targeting these specific capsular antigens, vaccines effectively prevent invasive disease and reduce the transmission of the bacteria within populations [5, 12].

Other names

Meningococcal A, C, Y, W-135 capsular polysaccharidesMenACWY antigensNeisseria meningitidis group A, C, Y, W-135 antigensQuadrivalent meningococcal antigensMeningococcal capsular polysaccharides (A, C, Y, W-135)

The antigens stimulate the production of serogroup-specific bactericidal antibodies [1, 13]. In conjugate vaccines, the polysaccharides are linked to carrier proteins to induce a T-cell dependent immune response, resulting in high-affinity antibodies and immunological memory [1, 7]. These antibodies facilitate the destruction of Neisseria meningitidis through opsonophagocytosis and complement-mediated lysis [3, 9].